{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:47:29Z","timestamp":1784166449419,"version":"3.55.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010571","name":"Federal Ministry of Education and Research Berlin Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01EE1405A"],"award-info":[{"award-number":["01EE1405A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.psychres.2025.116452","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T08:09:14Z","timestamp":1742544554000},"page":"116452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Unraveling antipsychotic induced weight gain in schizophrenia \u2013 A proof-of-concept study exploring the impact of the cumulative historical occupancy of different receptors by antipsychotics"],"prefix":"10.1016","volume":"348","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3195-806X","authenticated-orcid":false,"given":"Federico Pacheco","family":"Sudar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3155-2014","authenticated-orcid":false,"given":"Samar Samy","family":"Zekerallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Paulzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Mathiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8816-3415","authenticated-orcid":false,"given":"Arnim Johannes","family":"Gaebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116452_bib0001","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjp.0706929","article-title":"The MC4 receptor and control of appetite","volume":"149","author":"Adan","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pharmthera.2008.10.010","article-title":"Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors","volume":"121","author":"Aloyo","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2025.116452_bib0003","first-page":"121","article-title":"An animal model of antipsychotic-induced weight gain","volume":"152","author":"Arjona","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2025.116452_bib0004","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1016\/j.biopsych.2017.02.609","article-title":"Plasma cholesterol correlates negatively with positive symptoms of schizophrenia","volume":"81","author":"Babatope","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0005","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-18-0596","article-title":"The melanocortin pathway and control of appetite-progress and therapeutic implications","volume":"241","author":"Baldini","year":"2019","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.psychres.2025.116452_bib0006","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tem.2014.07.004","article-title":"Molecular pathophysiology of metabolic effects of antipsychotic medications","volume":"25","author":"Ballon","year":"2014","journal-title":"Trends Endocrinol. Metabolism"},{"key":"10.1016\/j.psychres.2025.116452_bib0007","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0269881115626349","article-title":"Betahistine decreases olanzapine-induced weight gain and somnolence in humans","volume":"30","author":"Barak","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2025.116452_bib0009","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuron.2004.10.009","article-title":"Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice","volume":"44","author":"Cannon","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2025.116452_bib0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/ph14030238","article-title":"Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences","volume":"14","author":"Carli","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.psychres.2025.116452_bib0011","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/schbul\/sbac041","article-title":"Maintenance treatment with antipsychotic drugs in schizophrenia: a Cochrane systematic review and meta-analysis","volume":"48","author":"Ceraso","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2025.116452_bib0012","first-page":"35","article-title":"Body mass index and mortality in patients with schizophrenia spectrum disorders: a cohort study in a South London catchment area","author":"Chen","year":"2022","journal-title":"Gen. Psychiatr."},{"key":"10.1016\/j.psychres.2025.116452_bib0013","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/sj.ijo.0801913","article-title":"The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis","volume":"25","author":"Cone","year":"2001","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.psychres.2025.116452_bib0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.64719\/pb.4134","article-title":"Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients","volume":"40","author":"Conley","year":"2007","journal-title":"Psychopharmacol. Bull."},{"issue":"1","key":"10.1016\/j.psychres.2025.116452_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2006.12.002","article-title":"A central thermogenic-like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2","volume":"5","author":"Coppola","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.psychres.2025.116452_bib0016","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2010.10.010","article-title":"Antipsychotic drugs and obesity","volume":"17","author":"Correll","year":"2011","journal-title":"Trends. Mol. Med."},{"issue":"2","key":"10.1016\/j.psychres.2025.116452_bib0017","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/wps.20994","article-title":"Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors","volume":"21","author":"Correll","year":"2022","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0018","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.cmet.2018.07.017","article-title":"Nucleus of the solitary tract serotonin 5-HT2C receptors modulate food intake","volume":"28","author":"D'Agostino","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.psychres.2025.116452_bib0019","first-page":"421","article-title":"Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation","volume":"46","author":"Dabire","year":"1991","journal-title":"Therapie"},{"key":"10.1016\/j.psychres.2025.116452_bib0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.jcp.0000117422.05703.ae","article-title":"Dose response and dose equivalence of antipsychotics","volume":"24","author":"Davis","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0021","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2147\/NDT.S113099","article-title":"Antipsychotic-associated weight gain: management strategies and impact on treatment adherence","author":"Dayabandara","year":"2017","journal-title":"Neuropsychiatr. Dis. Treatm."},{"key":"10.1016\/j.psychres.2025.116452_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106078","article-title":"Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective","volume":"176","author":"De Bartolomeis","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psychres.2025.116452_bib0023","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S1461145707007547","article-title":"Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis","volume":"10","author":"De Luca","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0024","article-title":"The impact of weight gain on antipsychotic nonadherence or discontinuation: a systematic review and meta-analysis","author":"De","year":"2024","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2025.116452_bib0025","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1523\/JNEUROSCI.4326-12.2013","article-title":"5-HT2C receptor agonist anorectic efficacy potentiated by 5-HT1B receptor agonist coapplication: an effect mediated via increased proportion of pro-opiomelanocortin neurons activated","volume":"33","author":"Doslikova","year":"2013","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.psychres.2025.116452_bib0026","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1210\/rp.59.1.395","article-title":"The central melanocortin system and the integration of short-and long-term regulators of energy homeostasis","volume":"59","author":"Ellacott","year":"2004","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.psychres.2025.116452_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005148.pub2","article-title":"Interventions to reduce weight gain in schizophrenia","author":"Faulkner","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.psychres.2025.116452_bib0028","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2005.01.054","article-title":"Effect of the activation of central 5-HT2C receptors by the 5-HT2C agonist mCPP on blood pressure and heart rate in rats","volume":"1040","author":"Ferreira","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.psychres.2025.116452_bib0029","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s42255-019-0099-7","article-title":"Hypothalamic dopamine signalling regulates brown fat thermogenesis","volume":"1","author":"Folgueira","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.psychres.2025.116452_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000441521","article-title":"Inflammatory cytokines and antipsychotic-induced weight gain: review and clinical implications","volume":"2","author":"Fonseka","year":"2016","journal-title":"Complex Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0031","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41398-023-02344-2","article-title":"Functional connectivity signatures of NMDAR dysfunction in schizophrenia\u2014Integrating findings from imaging genetics and pharmaco-fMRI","volume":"13","author":"Gaebler","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2025.116452_bib0032","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3390\/biomedicines10051096","article-title":"The interplay between vitamin D, exposure of anticholinergic antipsychotics and cognition in schizophrenia","volume":"10","author":"Gaebler","year":"2022","journal-title":"Biomedicines."},{"key":"10.1016\/j.psychres.2025.116452_bib0033","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.15223","article-title":"The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia","author":"Gaebler","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0034","first-page":"1","article-title":"Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor","author":"Gaitonde","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmet.2006.09.008","article-title":"Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency","volume":"4","author":"Gautam","year":"2006","journal-title":"Cell. Metab."},{"key":"10.1016\/j.psychres.2025.116452_bib0036","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/01621459.1961.10482095","article-title":"Note on stepwise least squares","volume":"56","author":"Goldberger","year":"1961","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.psychres.2025.116452_bib0037","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/nn1548","article-title":"Agouti-related peptide\u2013expressing neurons are mandatory for feeding","volume":"8","author":"Gropp","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psychres.2025.116452_bib0038","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCRESAHA.111.240226","article-title":"Ablation of the leptin receptor in the hypothalamic arcuate nucleus abrogates leptin-induced sympathetic activation","volume":"108","author":"Harlan","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.psychres.2025.116452_bib0039","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0014-2999(78)90297-2","article-title":"Antagonism of central histamine H1 receptors by antipsychotic drugs","volume":"52","author":"Hill","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbr.2006.03.040","article-title":"Olanzapine differentially affects 5-HT2A and 2C receptor mRNA expression in the rat brain","volume":"171","author":"Huang","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2025.116452_bib0041","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molmet.2017.01.001","article-title":"Cholinergic neurons in the dorsomedial hypothalamus regulate food intake","volume":"6","author":"Jeong","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.psychres.2025.116452_bib0042","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.beem.2014.03.003","article-title":"The hypothalamic arcuate nucleus and the control of peripheral substrates","volume":"28","author":"Joly-Amado","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.psychres.2025.116452_bib0043","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11357-016-9884-3","article-title":"Obesity and related consequences to ageing","volume":"38","author":"Jura","year":"2016","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.psychres.2025.116452_bib0044","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/diabetes.49.2.177","article-title":"Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone","volume":"49","author":"Kim","year":"2000","journal-title":"Diabet."},{"key":"10.1016\/j.psychres.2025.116452_bib0046","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase","volume":"104","author":"Kim","year":"2007","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.psychres.2025.116452_bib0047","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1639-8","article-title":"Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors","volume":"207","author":"Kirk","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2025.116452_bib0048","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.3390\/ijms20133207","article-title":"Potential utility of biased GPCR signaling for treatment of psychiatric disorders","volume":"20","author":"Komatsu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psychres.2025.116452_bib0049","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3390\/ijms19072017","article-title":"Integrating thyroid hormone signaling in hypothalamic control of metabolism: crosstalk between nuclear receptors","volume":"19","author":"Kouidhi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psychres.2025.116452_bib0050","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2025.116452_bib0051","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnsys.2015.00150","article-title":"Hypothalamic control of brown adipose tissue thermogenesis","volume":"9","author":"Labb\u00e9","year":"2015","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.psychres.2025.116452_bib0052","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","article-title":"Excess early mortality in schizophrenia","volume":"10","author":"Laursen","year":"2014","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.psychres.2025.116452_bib0053","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0895-4356(88)90119-9","article-title":"Assessing the importance of an independent variable in multiple regression: is stepwise unwise?","volume":"41","author":"Leigh","year":"1988","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.psychres.2025.116452_bib0054","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.06.010","article-title":"Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways","volume":"48","author":"Lian","year":"2014","journal-title":"Psychoneuroendocrinology."},{"key":"10.1016\/j.psychres.2025.116452_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.934384","article-title":"Does schizophrenia itself cause obesity?","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleh.2024.03.002","article-title":"Objectively measured daytime sleepiness predicts weight change among adults: findings from the Wisconsin Sleep Cohort Study","author":"Liu","year":"2024","journal-title":"Sleep. Health"},{"key":"10.1016\/j.psychres.2025.116452_bib0057","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1092852913000904","article-title":"Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia","volume":"19","author":"Loebel","year":"2014","journal-title":"CNS. Spectr."},{"key":"10.1016\/j.psychres.2025.116452_bib0058","unstructured":"L\u00f3pez-Mu\u00f1oz, F., \u00c1lamo Gonz\u00e1lez, C., et al., 2013. The pharmacological role and clinical applications of antipsychotics\u2019 active metabolites: paliperidone versus risperidone."},{"key":"10.1016\/j.psychres.2025.116452_bib0059","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1172\/JCI93362","article-title":"The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C","volume":"127","author":"Lord","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psychres.2025.116452_bib0060","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1517\/14728222.12.9.1167","article-title":"Muscarinic acetylcholine receptors as therapeutic targets for obesity","volume":"12","author":"Maresca","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.psychres.2025.116452_bib0061","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2133\/dmpk.20.368","article-title":"Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus","volume":"20","author":"Matsui-Sakata","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.psychres.2025.116452_bib0062","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2008.01317.x","article-title":"The metabolic syndrome and schizophrenia","volume":"119","author":"Meyer","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2025.116452_bib0063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-4-18","article-title":"The role of proopiomelanocortin (POMC) neurones in feeding behaviour","volume":"4","author":"Millington","year":"2007","journal-title":"Nutr. Metab. (Lond)"},{"key":"10.1016\/j.psychres.2025.116452_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.781946","article-title":"Dopamine receptor partial agonists: do they differ in their clinical efficacy?","volume":"12","author":"Mohr","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0065","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.euroneuro.2015.07.010","article-title":"Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: a pharmacoepidemiological-pharmacodynamic study in VigiBase","volume":"25","author":"Montastruc","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0066","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/pgs.11.55","article-title":"Relationship between P-glycoprotein and second-generation antipsychotics","volume":"12","author":"Moons","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.psychres.2025.116452_bib0067","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nature05026","article-title":"Central nervous system control of food intake and body weight","volume":"443","author":"Morton","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2025.116452_bib0068","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-021-04056-3","article-title":"Thalamic circuits for independent control of prefrontal signal and noise","volume":"600","author":"Mukherjee","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2025.116452_bib0069","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/tpj.2010.65","article-title":"Systematic analysis of dopamine receptor genes (DRD1\u2013DRD5) in antipsychotic-induced weight gain","volume":"12","author":"M\u00fcller","year":"2012","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.psychres.2025.116452_bib0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0306-4530(02)00114-2","article-title":"A review of the effect of atypical antipsychotics on weight","volume":"28","author":"Nasrallah","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2025.116452_bib0071","doi-asserted-by":"crossref","DOI":"10.2165\/00023210-200519001-00001","article-title":"Atypical antipsychotics and metabolic effects: a comprehensive literature review","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2025.116452_bib0072","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamapsychiatry.2015.2582","article-title":"Striatal reward activity and antipsychotic-associated weight change in patients with schizophrenia undergoing initial treatment","volume":"73","author":"Nielsen","year":"2016","journal-title":"JAMa Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0073","first-page":"1566","article-title":"Hypolipemic effects of histamine is due to inhibition of VLDL secretion from the liver: involvement of both H1 and H2-receptors. Archives of","volume":"128","author":"Nikfar","year":"2022","journal-title":"Physiol. Biochem."},{"key":"10.1016\/j.psychres.2025.116452_bib0074","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0075","first-page":"135","article-title":"Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein","volume":"278","author":"Ollmann","year":"1997","journal-title":"Science (1979)"},{"key":"10.1016\/j.psychres.2025.116452_bib0076","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tins.2007.06.004","article-title":"Is dopamine a physiologically relevant mediator of feeding behavior?","volume":"30","author":"Palmiter","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.psychres.2025.116452_bib0077","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/459284","article-title":"Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies","volume":"2011","author":"Panariello","year":"2011","journal-title":"Schizophr. Res. Treatment"},{"key":"10.1016\/j.psychres.2025.116452_bib0078","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(95)90469-7","article-title":"Prospects for pharmacotherapy of schizophrenia","volume":"345","author":"Pickar","year":"1995","journal-title":"The Lancet"},{"key":"10.1016\/j.psychres.2025.116452_bib0079","unstructured":"R Core Team, R., 2013. R: a language and environment for statistical computing."},{"key":"10.1016\/j.psychres.2025.116452_bib0080","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.HYP.0000254827.59792.b2","article-title":"Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin","volume":"49","author":"Rahmouni","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.psychres.2025.116452_bib0081","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1359786806066040","article-title":"The 5-HT2C receptor and antipsychoticinduced weight gain\u2013mechanisms and genetics","volume":"20","author":"Reynolds","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0082","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/11596300-000000000-00000","article-title":"Atypical antipsychotic-induced weight gain: insights into mechanisms of action","volume":"25","author":"Roerig","year":"2011","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.psychres.2025.116452_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v048.i02","article-title":"lavaan: an R package for structural equation modeling","volume":"48","author":"Rosseel","year":"2012","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.psychres.2025.116452_bib0084","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.psychres.2025.116452_bib0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/beem.2002.0230","article-title":"Hypothalamic regulation of energy homeostasis","volume":"16","author":"Sainsbury","year":"2002","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.psychres.2025.116452_bib0086","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0006-8993(88)91423-0","article-title":"Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation","volume":"441","author":"Sakata","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.psychres.2025.116452_bib0087","first-page":"10","article-title":"Agomelatine: a novel antidepressant","volume":"8","author":"Sansone","year":"2011","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.psychres.2025.116452_bib0088","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s002130050407","article-title":"5-HT2C receptor activation decreases appetite and body weight in obese subjects","volume":"133","author":"Sargent","year":"1997","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2025.116452_bib0089","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.mp.4000336","article-title":"Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors","volume":"3","author":"Seeman","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0090","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2217\/pgs.10.123","article-title":"Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis","volume":"11","author":"Sicard","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.psychres.2025.116452_bib0091","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/17512433.2020.1703109","article-title":"Efficacy and safety of lorcaserin in obesity: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Singh","year":"2020","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0092","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1210\/en.2009-0804","article-title":"Hypothalamic and hindbrain melanocortin receptors contribute to the feeding, thermogenic, and cardiovascular action of melanocortins","volume":"150","author":"Skibicka","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.psychres.2025.116452_bib0093","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/oby.2008.537","article-title":"Lorcaserin (APD356), a selective 5-HT2C agonist, reduces body weight in obese men and women","volume":"17","author":"Smith","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.psychres.2025.116452_bib0094","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/oby.2008.468","article-title":"The role of thermogenesis in antipsychotic drug-induced weight gain","volume":"17","author":"Stefanidis","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.psychres.2025.116452_bib0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","article-title":"Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice","volume":"33","author":"Sugino","year":"2009","journal-title":"Prog Neuro-Psychopharmacol. Biolog. Psychiat."},{"key":"10.1016\/j.psychres.2025.116452_bib0096","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0896-6273(01)00319-1","article-title":"Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice","volume":"30","author":"Szczypka","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2025.116452_bib0097","first-page":"4","article-title":"Antipsychotics in the treatment of schizophrenia: an overview","volume":"72","author":"Tandon","year":"2011","journal-title":"J. Clin. p"},{"key":"10.1016\/j.psychres.2025.116452_bib0098","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/jpm13030471","article-title":"The progress and pitfalls of pharmacogenetics-based precision medicine in Schizophrenia spectrum disorders: a systematic review and meta-analysis","volume":"13","author":"Teng","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.psychres.2025.116452_bib0099","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/npp.2016.264","article-title":"Activation of ventral tegmental area 5-HT2C receptors reduces incentive motivation","volume":"42","author":"Valencia-Torres","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2025.116452_bib0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tem.2019.01.003","article-title":"Antipsychotics promote metabolic disorders disrupting cellular lipid metabolism and trafficking","volume":"30","author":"Vantaggiato","year":"2019","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"10.1016\/j.psychres.2025.116452_bib0101","first-page":"83","article-title":"Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gain","author":"Wallace","year":"2011","journal-title":"Pharmgenomics. Pers. Med."},{"key":"10.1016\/j.psychres.2025.116452_bib0102","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/JCP.0b013e3181d2ef6f","article-title":"Higher motor activity in schizophrenia patients treated with olanzapine versus risperidone","volume":"30","author":"Walther","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-020-02809-4","article-title":"Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2025.116452_bib0104","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance","volume":"66","author":"Weiden","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116452_bib0105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.euroneuro.2011.09.003","article-title":"Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels","volume":"22","author":"Weston-Green","year":"2012","journal-title":"European Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116452_bib0106","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/schbul\/sbac001","article-title":"Antipsychotic-induced weight gain: dose-response meta-analysis of randomized controlled trials","volume":"48","author":"Wu","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2025.116452_bib0107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35065604","article-title":"Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean","volume":"410","author":"Yamada","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2025.116452_bib0108","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41366-023-01291-8","article-title":"Mechanism and treatments of antipsychotic-induced weight gain","volume":"47","author":"Ye","year":"2023","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.psychres.2025.116452_bib0109","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.609240","article-title":"A focused review of the metabolic side-effects of clozapine","volume":"12","author":"Yuen","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.psychres.2025.116452_bib0110","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/schbul\/sbw058","article-title":"Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis","volume":"42","author":"Zhang","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2025.116452_bib0111","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/nn.4372","article-title":"Hypothalamic arcuate nucleus tyrosine hydroxylase neurons play orexigenic role in energy homeostasis","volume":"19","author":"Zhang","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psychres.2025.116452_bib0112","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0092-8674(95)90145-0","article-title":"Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic","volume":"83","author":"Zhou","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.psychres.2025.116452_bib0113","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fnbeh.2016.00066","article-title":"Activity of D1\/2 receptor expressing neurons in the nucleus accumbens regulates running, locomotion, and food intake","volume":"10","author":"Zhu","year":"2016","journal-title":"Front. Behav. Neurosci."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:45:37Z","timestamp":1777956337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":113,"alternative-id":["S0165178125001015"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116452","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling antipsychotic induced weight gain in schizophrenia \u2013 A proof-of-concept study exploring the impact of the cumulative historical occupancy of different receptors by antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116452"}}